Pfizer to buy biotech group Biohaven for $11.6bn - Financial Times

1. Pfizer to buy biotech group Biohaven for $11.6bn  Financial Times
2. Cash-rich Pfizer to pay $11.6 billion for Biohaven in biggest deal since 2016  CNBC
3. Biohaven Pharmaceuticals shares surge after Pfizer agrees to acquire company  CNBC Television
4. BHVN Stock Rockets: Pfizer Snaps Up Biohaven For Nearly $12 Billion  Investor's Business Daily
5. XBI rebounds on PFE BHVN deal (NYSE:PFE)  Seeking Alpha
6. View Full Coverage on Google News

from Top stories - Google News https://ift.tt/7cHJBon
via IFTTT